Inventor · disambiguated record
Titus Kretzschmar
Also filed as: KRETZSCHMAR TITUS
18 granted patents·8 pending applications·494 citations·filing 1998–2022
95Inventor score
Files withCELL MEDICA INC7CELL MEDICA SWITZERLAND AG5BARDROFF MICHAEL2DELENEX THERAPEUTICS AG2HOFFMANN LA ROCHE2
Top patents by PatentIndex Score
26 records- 0195US7794719B2Anti-amyloid β antibodiesHOFFMANN LA ROCHE·Filed 2003·Granted Sep 14, 2010·77 cites·9 claims
- 0292US8329886B2Nucleic acid molecules encoding anti-amyloid beta antibodiesBARDROFF MICHAEL·Filed 2012·Granted Dec 11, 2012·22 cites·33 claims
- 0391US6653068B2Generation of specific binding partners binding to (poly)peptides encoded by genomic DNA fragments or ESTsMORPHOSYS AG·Filed 2001·Granted Nov 25, 2003·95 cites·32 claims
- 0491US6495357B1Lipolytic enzymesNOVOZYME AS·Filed 1998·Granted Dec 17, 2002·146 cites·63 claims
- 0590US8216577B2Anti-Aβ antibodies and their useBARDROFF MICHAEL·Filed 2009·Granted Jul 10, 2012·14 cites·12 claims
- 0689US6368805B1Methods of producing polynucleotide variantsNOVOZYMES AS·Filed 2000·Granted Apr 9, 2002·26 cites·31 claims
- 0788US6159688AMethods of producing polynucleotide variantsNOVO NORDISK AS·Filed 1998·Granted Dec 12, 2000·77 cites·28 claims
- 0886US7157262B2Lipolytic enzymesNOVOZYMES AS·Filed 2002·Granted Jan 2, 2007·14 cites·14 claims
- 0973US9404930B2Antibody to human IL-1 betaDELENEX THERAPEUTICS AG·Filed 2013·Granted Aug 2, 2016·2 cites·23 claims
- 1073US2023203151A1Antibodies Against IL-1 BetaCELL MEDICA INC·Filed 2022·Application pending·0 cites
- 1171US10077302B2Method of inhibiting human IL-1 beta by administering an antibody to human IL-1 betaCELL MEDICA SWITZERLAND AG·Filed 2016·Granted Sep 18, 2018·1 cites·24 claims
- 1271US2022220195A1Antibody to human il-1 betaCELL MEDICA INC·Filed 2022·Application pending·0 cites
- 1370US11434294B2Binding members to PD-L1CELL MEDICA INC·Filed 2017·Granted Sep 6, 2022·1 cites·18 claims
- 1469US10626171B2Nucleic acid encoding antibody to human IL-1 betaCELL MEDICA SWITZERLAND AG·Filed 2018·Granted Apr 21, 2020·0 cites·20 claims
- 1569US10233238B2TNF alpha antibody or fragment thereof and methods of useCELL MEDICA SWITZERLAND AG·Filed 2015·Granted Mar 19, 2019·1 cites·24 claims
- 1668US11267884B2Antibody to human IL-1 betaCELL MEDICA INC·Filed 2020·Granted Mar 8, 2022·0 cites·19 claims
- 1766US10995138B2Nucleic acids encoding binding members to TNF alphaCELL MEDICA SWITZERLAND AG·Filed 2019·Granted May 4, 2021·0 cites·22 claims
- 1866US2023235061A1Binding Members to PD-L1CELL MEDICA INC·Filed 2022·Application pending·0 cites
- 1965US6291165B1Shuffling of heterologous DNA sequencesNOVO NORDISK AS·Filed 1998·Granted Sep 18, 2001·18 cites·24 claims
- 2065US2021332119A1Binding members to tnf alphaCELL MEDICA INC·Filed 2021·Application pending·0 cites
- 2164US11407824B2Nucleic acids encoding antibodies against IL-1 betaCELL MEDICA INC·Filed 2020·Granted Aug 9, 2022·0 cites·16 claims
- 2259US2018258165A1Antibodies against il-1 betaCELL MEDICA SWITZERLAND AG·Filed 2018·Application pending·0 cites
- 2357US2013136747A1Anti-amyloid beta antibodies and their useHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 2456US9914772B2Antibodies against IL-1 betaDELENEX THERAPEUTICS AG·Filed 2015·Granted Mar 13, 2018·0 cites·34 claims
- 2555US2004157291A1Generation of specific binding partners binding to (poly)peptides encoded by genomic DNA fragments or ESTsMORPHOSYS AG·Filed 2003·Application pending·0 cites
- 2652US2022323380A1Drug combination for use in the treatment of inflammatory diseasesISANAS AG·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →